| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 268,279 | 242,795 | 223,465 | 351,682 | | Cost of Revenue | 194,838 | 185,087 | 162,191 | 295,074 | | | Gross Profit | 73,441 | 57,708 | 61,274 | 56,608 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 89,365 | 79,343 | 76,769 | 99,845 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (15,924) | (21,635) | (15,495) | (43,237) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (17) | 66 | (229) | 2,830 | | Earnings Before Interest And Taxes | (15,941) | (21,569) | (15,724) | (40,407) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (15,941) | (21,569) | (15,724) | (40,407) | | Income Tax Expense | (5,036) | (7,414) | (6,981) | (12,943) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,905) | (14,155) | (8,743) | (27,464) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 422 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,905) | (14,155) | (8,743) | (27,042) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,905) | ($14,155) | ($8,743) | ($27,042) |
|
0.16% Nasdaq 
Income Statement
